What is Opus Genetics's asset turnover?

Opus Genetics (IRD) reported asset turnover of 0.2× in Q1 2026.

How has Opus Genetics's asset turnover changed year-over-year?

Opus Genetics's asset turnover decreased by 23.6% year-over-year, from 0.3× to 0.2×.

What does asset turnover mean?

Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.

Opus Genetics IRD Asset turnover

Asset turnover at other companies

AbbVieABBV

0.5×+0.1×

MeiraGTx Holdings plcMGTX

0.3×+0.2×

4D Molecular TherapeuticsFDMT

0.2×—

Opko HealthOPK

0.3×0.0×

Regeneron PharmaceuticalsREGN

0.4×0.0×

RegenxbioRGNX

0.2×-0.1×

Other financials

Income statement

See full

Revenue$2.2M-50.6%

Operating income-$14.4M-44.7%

Net income-$65.5M-700%

EPS (diluted)-$0.75-213%

Balance sheet

See full

Cash & equivalents$60.0M+43.5%

Total debt$1.2M—

Total equity-$45.8M-1,004%

Total assets$66.8M+38.7%

Cash flow

See full

Operating cash flow-$12.7M-41.5%

Valuation

See full

Market cap$307.14M+442%

Enterprise value$248.38M—

P/S25.6×+21.5×

Profitability

See full

Operating margin-359.1%-68.9pp

Net margin-892.4%-12,322pp

Returns & leverage

See full

Return on equity-449.4%-2,573pp

Debt / equity0.1×—

Current ratio7.1×+5.2×

Where this comes from

Calculated from Opus Genetics’s reported figures.

total revenue/total assets=0.2×

Based on trailing twelve months.

The official record: Opus Genetics’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Opus Genetics's asset turnover.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Opus Genetics's asset turnover?: Opus Genetics (IRD) reported asset turnover of 0.2× in Q1 2026.
How has Opus Genetics's asset turnover changed year-over-year?: Opus Genetics's asset turnover decreased by 23.6% year-over-year, from 0.3× to 0.2×.
What does asset turnover mean?: Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.